Prostate-specific antigen in prostate cancer: A case study in the development of a tumor marker to monitor recurrence and assess response
- 1 June 2002
- journal article
- review article
- Published by Elsevier in Seminars in Oncology
- Vol. 29 (3) , 264-273
- https://doi.org/10.1053/sonc.2002.32902
Abstract
No abstract availableKeywords
This publication has 56 references indexed in Scilit:
- Cancer Statistics, 2001CA: A Cancer Journal for Clinicians, 2001
- Combination of Prostate-Specific Antigen, Clinical Stage, and Gleason Score to Predict Pathological Stage of Localized Prostate CancerJAMA, 1997
- The effect of Digital Rectal Examination, Flexible Cystoscopy and Prostatic Biopsy on Free and Total Prostate Specific Antigen, and the Free-to-Total Prostate Specific Antigen Ratio in Clinical PracticeJournal of Urology, 1997
- Serum Markers as a Predictor of Response Duration and Patient Survival After Hormonal Therapy for Metastatic Carcinoma of the ProstateJournal of Urology, 1997
- Time to second prostate-specific antigen failure is a surrogate endpoint for prostate cancer death in a prospective trial of therapy for localized diseaseUrology, 1996
- Clinical usefulness of free PSA fraction as an indicator of prostate cancerInternational Journal of Cancer, 1995
- Free, Complexed and Total Serum Prostate Specific Antigen: The Establishment of Appropriate Reference Ranges for their Concentrations and RatiosJournal of Urology, 1995
- Measurement of the proportion of free to total prostate-specific antigen improves diagnostic performance of prostate-specific antigen in the diagnostic gray zone of total prostate-specific antigenUrology, 1995
- Serum concentrations of prostate specific antigen and its complex with α1-antichymotrypsin before diagnosis of prostate cancerThe Lancet, 1994
- Measurement of Prostate-Specific Antigen in Serum as a Screening Test for Prostate CancerNew England Journal of Medicine, 1991